EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

KNOWLEDGE ATTITUDE AND PRACTICE OF PHARMACOVIGILANCE WITHIN HEALTH PROFESSIONALS, PHARMACEUTICAL COMPANIES AND DRUG REGULATORY ORGANIZATION IN CAMEROON

Estella Achick Tembe Fokunang, Bayaga Herve, Tchadji Mayoudom Vanessa Edwige, Nene Ahidjo, Tabi Yves Omgba, Bruna Beri Mbonn Njeba, Lovet Benyella Fokunang, Marie Jose Essi, Marie Therese Abena Obama Ondoua and Charles Ntungwen Fokunang

ABSTRACT

The drug discovery and development processes are designed to guarantee that medicines have the right quality, safety and efficacy. Unfortunately, the number of patients and volunteers who are exposed to drugs at approval gives only a small part of the story of adverse effects. It is therefore, mandatory in understanding the safety of medicines before and after approval by regulatory bodies. This post marketing surveillance can only be finally achieved after the drug is on the market through pharmacovigilance data. Health professionals, patients, drug manufacturers and drug regulatory authorities are therefore highly involved in the practice of pharmacovigilance (PHV). Cameroon imports 95 % of drugs and health care products. Therefore, an effective understanding of the knowledge, attitude and practice of Pharmacovigilance within the health sector by actors, would enhance the elaboration of the development of a good collaborative pharmacovigilance system platform in any country. This study has as objective to investigate the knowledge, attitude and practice of pharmacovigilance within health personnel, pharmaceutical companies and drug regulatory organs of the public health sector in Cameroon. A cross sectional, descriptive and analytical study was conducted in the Yaoundé Central Hospital (a Reference hospital), 50 pharmacies of the Mfoundi District and in 11 Pharmaceutical company representative offices in Yaoundé, and the Drug regulatory organ in Cameroon. The survey was conducted using a pre- tested self- administered questionnaire. A well-structured questionnaire for each study groups were. developed and used to pull data from the different study group. The data for health professionals and pharmaceutical companies was entered and analyzed using Epi-Info Version 3.5.4 statistical software and presented using Microsoft Excel spreadsheet. A total of 162 professionals composed of 11 (6.8%) Pharmaceutical companies representative office supervisors, 101(62.3%) Hospital personnel and 50(30.9%) Pharmacy personnel. These populations were subdivided into Hospital personnel comprising 8(4.9%) Specialists, 47(29%) General practitioners, 10(6.2%) Dentists, 30(18.5%) Nurses and 6(3.7%) midwives. Pharmacy personnel comprised of; 4(2.5%) Advanced level, 3(1.9%) HND (Higher National Diploma) or pharmacy technicians, 4(2.5%) bachelors holders and 39(24.1%) pharmacists. In the general appreciation of knowledge, 58% of pharmacy personnel, 52.9% of hospital personnel and 65.7% of pharmaceutical company representative supervisors had the right appreciation. For attitudes, 52% of pharmacy personnel, 43.4% of hospital personnel and 53.3% of pharmaceutical company representative supervisors had the expected results. For practice, 25.1% of pharmacy personnel, 17.5% of hospital personnel and 44.6% of pharmaceutical company representative supervisors had the right practice. This summed up to give a general appreciation of 33% for pharmacy personnel, 28% for hospital personnel and 39% for pharmaceutical companies, had a better appreciation of pharmacovigilance. Generally, there was little applicable knowledge which determined the poor attitudes developed towards pharmacovigilance among the health professionals and pharmaceutical companies leading to poor practice. Given that these are key actors in the pharmacovigilance system, these results are seen to cause the problem of underdevelopment in our Pharmacovigilance systems. This study calls for the need to scale up the technical platform and organization of a well-developed pharmacovigilance system in Cameroon.

Keywords: Adverse drug reactions, Health Professional, Pharmacy personnel, Pharmaceutical company, Drug regulators, Yaoundé, Cameroon.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • EJPMR: JANUARY ISSUE PUBLISHED

    JANUARY issue has been successfully launched on 1 JANUARY 2023.

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 January 2023 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database